Smartleaf Asset Management’s Sana Biotechnology SANA Stock Holding History

Smartleaf Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83K	Hold	532	–	–	﹤0.01%	2973
2026 Q1	$1.43K	Hold	532	–	–	﹤0.01%	3047
2025 Q4	$2.17K	Hold	532	–	–	﹤0.01%	2965
2025 Q3	$1.88K	Buy	532 +346	+186%	+$1.25K	﹤0.01%	2633
2025 Q2	$522	Sell	186 -115	-38%	-$237	﹤0.01%	2581
2025 Q1	$514	Sell	301 -1,091	-78%	-$3.05K	﹤0.01%	2693
2024 Q4	$2.24K	Buy	+1,392	New	+$4.15K	﹤0.01%	2504
2024 Q3	–	Sell	-597	Closed	-$3.22K	–	2973
2024 Q2	$3.22K	Buy	+597	New	+$4.76K	﹤0.01%	2014

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Smartleaf Asset Management's SANA Position: Q2 2026 in Review

Smartleaf Asset Management held its Sana Biotechnology (SANA) position steady in Q2 2026 at 532 shares worth $1.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

Smartleaf Asset Management first reported a position in SANA in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.22K in Q2 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Smartleaf Asset Management held 532 shares of Sana Biotechnology worth $1.83K as of Q2 2026.
Smartleaf Asset Management left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2973 holding.
Smartleaf Asset Management first reported a position in Sana Biotechnology in Q2 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's Sana Biotechnology position peaked at $3.22K in Q2 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.